BM
VRDN icon

Bridger Management’s Viridian Therapeutics VRDN Stock Holding History

Bridger Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-66,300
Closed -$767K – 48
2022
Q2 		$767K Buy
+66,300
New +$891K 0.17% 39

Other funds holding VRDN

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridger Management's VRDN Position: Q3 2022 in Review

Bridger Management sold out of Viridian Therapeutics (VRDN) in Q3 2022, closing a stake of 66,300 shares — an estimated $767K sold.

Bridger Management first reported a position in VRDN in Q2 2022 and held it in 1 quarter. The position peaked at $767K in Q2 2022. 105 funds tracked by Wall St. Rank hold VRDN as of Q3 2022.

  • Bridger Management reported no remaining Viridian Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bridger Management sold 66,300 Viridian Therapeutics shares in Q3 2022, an estimated $767K.
  • Bridger Management first reported a position in Viridian Therapeutics in Q2 2022 and held it in 1 quarter.
  • Bridger Management's Viridian Therapeutics position peaked at $767K in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2022.

Based on Bridger Management's 13F filing for Q3 2022, filed 14 Nov 2022.